CytRx Corporation cytrx.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1132)

CytRx Corporation (NASDAQ: CYTR), located in Los Angeles, California, is a biopharmaceutical research and development company specializing in oncology. CytRx currently is focused on the clinical development of aldoxorubicin (formerly known as INNO-206), its improved version of the widely used chemotherapeutic agent doxorubicin. CytRx has initiated under a special protocol assessment a pivotal Phase 3 global trial with aldoxorubicin as a therapy for patients with soft tissue sarcomas whose tumors...Show all

CytRx Corporation (NASDAQ: CYTR), located in Los Angeles, California, is a biopharmaceutical research and development company specializing in oncology. CytRx currently is focused on the clinical development of aldoxorubicin (formerly known as INNO-20...Show all

Company (IPO / Went public)

Phone: 310-826-5648

Fax:

11726 San Vicente Boulevard
Suite 650
Los Angeles, 90049
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
CytRx Corporation $71.8M Apr 23, 2007

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related CytRx Corporation Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 42 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.